00:00 / 00:00
An arrhythmia is any disturbance in the rate, rhythm, site of origin, or conduction of the cardiac electrical impulse. Supraventricular arrhythmias are a group of cardiac arrhythmias that originate at or above the atrioventricular node and have a narrow QRS complex (<120 ms). Supraventricular arrhythmias include atrial fibrillation, atrial flutter, and supraventricular tachycardia.
Supraventricular arrhythmias can cause a patient's heart rate to become too fast (tachycardia) or too slow (bradycardia). They can also cause stasis of blood flow in the atrial compartment and increase the risk of clot formation, especially in the left atrial appendage. These clots can dislodge, and travel into the systemic circulation, causing potentially life-threatening pathologies like embolic strokes, acute limb ischemia, central retinal artery occlusion, or acute mesenteric ischemia.
Common symptoms seen in supraventricular arrhythmias include palpitations, dizziness, shortness of breath, and chest pain. Treatment for these arrhythmias usually involves medications like beta-blockers, calcium channel blockers, digoxin, and other antiarrhythmic drugs; or procedures like electrical cardioversion and catheter ablation. In some cases, lifestyle modifications may be recommended to reduce the risk of developing arrhythmias.
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.